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Aim: Evaluation of early experience with implant based breast reconstruction for early breast cancer in ptotic
breasts with titanium coated polypropylene mesh and lower pole dermal sling.
Methods: A pilot prospective ongoing study where patients having immediate implant based reconstruction with
non biological mesh and lower pole dermal sling are evaluated simultaneously. Patient, surgical, and tumour
related factors are presented as well as the cosmetic outcome in five patients, two of whom underwent bilateral
procedure for bilateral breast cancer and one who underwent simultaneous symmetrisation with reduction
mammoplasty on the contralateral side.
Results: All five patients had good cosmetic outcome with minor complications. There was no delay in adjuvant
treatment due to complications. All were satisfied with their results and would recommend this treatment to others.
Conclusion: Using a non biological mesh as well as a lower pole dermal sling, which covers the suture line and offers
an extra layer of protection to the mesh, reduces the complication rate especially in patients who may be at higher risk
of wound related problems such as those with increased body mass index. This procedure is also cost effective
(non biological meshes are only 1/5th of the cost compared to biological meshes) and provides equivalent
cosmetic outcomes in a select group of patients.
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The incidence of breast cancer continues to increase
throughout the world. In 2011, there were 50,285 new
cases of breast cancer in the UK. 49,936 (99 %) in
women and 349 (less than 1 %) in men [1]. Patients with
early breast cancer who need to undergo mastectomy
are offered immediate as well as delayed reconstruction
routinely in the UK. Nearly 30 % of patients (national
mastectomy breast reconstruction (NMBRA) audit) in the
immediate reconstruction setting opted to have implant
based reconstruction after weighing up all the options avail-
able to them. With the availability of various biological and* Correspondence: rrathinaezhil@nhs.net
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medium, provided the original work is proper
creativecommons.org/publicdomain/zero/1.0/non biological meshes, good cosmetic outcome can be
achieved at the present time [2].
The cost of biological meshes can be a prohibitive fac-
tor in offering this to all patients requiring implant
based reconstruction [3]. Non biological meshes as an
alternative are cost effective and can be substituted for
biological meshes [4].
There are several publications supporting the use of
non biological meshes and claiming equivalent cosmetic
outcomes to biological meshes [5–8]. In patients with
significant ptosis where skin reduction is also necessary,
a lower pole dermal sling (the patient’s own biological
mesh) can be used for breast reconstruction [9, 10].
We would like to present our early experience of com-
bining the non biological mesh with the lower pole dermal
sling in patients with significant ptosis who need skiness article distributed under the terms of the Creative Commons Attribution
by/4.0), which permits unrestricted use, distribution, and reproduction in any
ly credited. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Table 1 Patient related factors
Patient 1 Patient 2 Patient 3 Patient 4 Patient 5
Age 42 47 55 59 62
BMI 22 34 26 31 33
Smoking habit Non smoker Yes. Gave up at
diagnosis





Alcohol intake per week Very occasional None Occasional 14 units/week None
Drugs including steroids None None None None None
Connective tissue and vasculitic
disorders
None None None None None
Diabetes No No No No No
Other co morbidities None Asthma None None None
Skin quality Very good Good Good Good Good
Degree of ptosis 3 3 2 3 3







Aware of the possibility
on the right
Aware Unlikely as DCIS Aware of the possibility
on both sides
BMI body mass index, DCIS ductal carcinoma in situ
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good cosmetic outcome.Patient details and methods
All patients consented to take part in the study and this
study was fully compliant with the Helsinki declaration.Table 2 Surgery related factors
Patient 1 Patient 2
Antibiotic prophylaxisa Yes Yes
Duration of antibiotic
prophylaxisb
7 days 14 days
Skin prep used Chlorhexidine Chlorhexidine
Method of dissection to
raise skin flaps and dermal
sling
Diathermy Diathermy

















7 days 10 days
Laminar flow usage Yes Yes
Post-op follow up 1 week 2 weeks
Mastectomy specimen
weight
496 g R-905 g
L-885 g
a2 g flucloxacillin and 160 mg gentamicin or in those with penicillin allergy; 600 mg
bDuration decided by the operating surgeonThe treatment that patients underwent was the standard
of care for their disease and as this study only looks into
an innovative surgical technique, ethics approval was not
required.
We have done seven procedures in five patients (two
bilateral procedures for bilateral breast cancer). The age
distribution in this cohort was 42–62 and the mean agePatient 3 Patient 4 Patient 5
Yes Yes Yes




















2 2 2 on each side
7 days 7 days 10 days
Yes Yes Yes
1 week 1 week 1 week
600 g 1071 g R-454 g
L-464 g
teicoplanin and 160 mg gentamicin









No of nights spent in
hospital
5 10 3 5 3















None None None None None
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to undergo implant based reconstruction after reviewing
the reconstruction literature and detailed discussion with
the specialist breast care nurse.
The details of patient related factors such as age, BMI,
smoking status, co-morbidities, drug intake including
steroid intake, alcohol consumption, skin quality, contra-
lateral breast surgery, degree of ptosis, and knowledge
about post-operative radiotherapy and its implications
are given in Table 1.
Surgery related factors such as antibiotic prophylaxis
(intra-operative and post-operative), skin prep used,
method of dissection to raise the dermal sling and mastec-
tomy flap, mastectomy specimen weight, cavity washout,
change of gloves, laminar flow usage, type and number of
drains used, duration for which drains were left in, fre-
quency of post-operative follow up are detailed in Table 2.Table 4 Tumour related factors




83 mm R-40 mm,
L-8 mm
9 mm w
Grade 2 R-3, L-2 3











ER status 7 R-2, L-7 8
PR status 8 R-NK,
L-6
8
HER2 status Negative R-Positive Negativ
L-Negative
ADH atypical ductal hyperplasia, LVI lymphovascular invasion, ER oestrogen receptoThe details of the hospital stay, immediate postopera-
tive issues, tumour related factors, adjuvant, neoadjuvant
treatments as well as further surgery planned are given
in Tables 3, 4 and 5.
Surgical technique
The patients were marked with a standard Wise pattern
incision, with a 7.5–9 cm vertical incision (depending on
the patient’s body habitus). Once de-epithelialisation of
the skin was done, skin flaps, and dermal sling were
raised and the breast disc was lifted from the pectoralis
major and the mastectomy was performed in the stand-
ard manner.
The pectoralis major muscle was then raised by divid-
ing it inferiorly and medially at the level of the infra
mammary fold and a sub pectoral pocket was created.
The synthetic non biological mesh (Ti Loop®) was fixed
to the pectoralis muscle with 2/0 absorbable sutures
to complete the pocket. The permanent fixed volume
implant chosen was placed in the pocket and the mesh
was fixed to the inframammary fold as well as laterally
along the anterior axillary line to prevent lateral
displacement.
Finally the dermal sling overlying the mesh was fixed
to the muscle and the wound closed in layers with two
low pressure vacuum drains. Patients were advised to
wear a support bra for 6 weeks.
The technique is summarized in Figs. 1 and 2.
Complications
There were no major complications and the only minor
complication encountered was “T” junction and skin
edge necrosis which settled with conservative measures.3 Patient 4 Patient 5
ith ADH 7 mm invasive and
100 mm in situ
R-100 mm, L-55 mm
3 3
ductal Invasive micropapillary Invasive lobular
carcinoma





e Positive Negative on both sides
r, PR progesterone receptor, DCIS ductal carcinoma in situ
Table 5 Adjuvant and neoadjuvant treatment and further surgery planned






No Yes No No No
Neoadjuvant endocrine
therapy
No No No No No
Adjuvant chemotherapy Yes No No No Yes
Adjuvant endocrine
therapy
Planned Yes Yes No Yes
Adjuvant radiotherapy Planned Yes only to the right No No Yes
Targeted therapy No Yes No No No




Possible free flap reconstruction–
patient choice
Patient not keen on
symmetrisation
No No
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up. The fifth patient had surgery less than 3 months ago.
Patient reported outcome measures (PROMS) were
assessed in four patients with breast Q questionnaire after
obtaining informed consent 3 months post-operatively.
The details are given in Table 6. The last patient declined
consent for evaluation.
Results
All five patients were satisfied with the care and infor-
mation they received. They were also satisfied with the
cosmetic outcome from the reconstruction at this early
follow up although admittedly this may change with
longer follow up as well as with adjuvant radiotherapy.
A random selection of 15 allied health professionals
and administrative staff, who were not directly in-
volved in patient care, were asked to score the cos-
metic outcome in four patients (one patient declined
post-operative photographs). They were shown photo-
graphs of the breasts 3 months post-op and asked to
score them between 1 and 10, where 1 = poor cosmetic
appearance and 10 = excellent cosmetic appearance. In
general, the scores were very encouraging with the
average rating being 7.4–7.7. However the small sam-
ple size should be taken into context. The full details
are given in Table 7.
Conclusion
The availability of biological and non biological meshes
have improved the cosmetic outcome of implant based
reconstruction. The use of the mesh as a hammock in
the lower pole and attaching it to the divided pectoralis
major muscle enables us to reconstruct the breast using
with larger volume implants with much less discomfort,
quicker recovery, and better cosmetic outcome. This
also avoids donor site scar and its associated morbidityin patients who are not keen to have other forms of
reconstruction.
Our initial experience suggests that this technical
innovation is an excellent alternative for patients with
ptosis where skin reduction is needed. This negates the
need to raise the serratus anterior muscle as required
when the dermal sling alone is used for implant based
reconstruction. This increases the post-operative pain
considerably compared to our technique. In this method,
the patient’s own dermis can be used as a biological
mesh to cover the non-biological mesh along the Wise
pattern scar line, thereby protecting the mesh, and the
implant in the unfortunate incidence of wound compli-
cations and providing an additional layer of protection
with no increased morbidity from the procedure.
We accept that some critics might question the use of
both the non biological mesh and the dermal sling and
enquire what additional benefit is conferred by using
both rather than one or the other. The answer is that
with the dermal sling it is not always possible to achieve
complete closure for the implant laterally and medially.
This necessitates the need to raise the serratus anterior
muscle which causes reasonable discomfort at least in
the initial post-operative period. Our technique avoids
the need to disturb serratus anterior. The use of a non
biological mesh is also associated with lower rates of
post-operative seroma formation which require aspiration.
This is thought to be due to the perforations which
most biological meshes lack with the exception of the
fenestrated bovine acellular dermal matrix.
We acknowledge that no definite conclusion can be
made from our initial experience of combining non bio-
logical mesh and dermal sling in patients having implant
based reconstruction. However this procedure could be
considered as an alternative to using biological mesh or
dermal sling in implant based reconstruction in select
Fig. 1 Schematics step by step summary of surgical technique
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Fig. 2 Illustrations of the step by step summary of surgical technique
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Management of pain in the











None None None None
Complications requiring
treatment on an outpatient











Number of visits to surgical
outpatients since discharge
4 5 3 3
aPROMS not reported for patient 5 as she declined consent
Table 7 Observer ratings of cosmetic appearance at 3 months
(1 = poor, 10 = excellent)a
Patient 1 Patient 2 Patient 3 Patient 4
Mean 7.4 7.4 7.7 7.7
Median 7 8 8 8
Mode 7,8 8 8, 9 8,9
Range 6–9 5–9 4–9 4–9
aObserver ratings not reported for patient 5 as she declined further follow
up pictures
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in units where the use of a biological mesh is prohibitive
due to high expenses.
We intend to publish our results with more numbers
and longer follow up in the future as we will continue to
offer this procedure to selected patients who opt to have
implant based breast reconstruction.
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